CDXS Insider Transactions — Page 4
344 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 301–344; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Yang Patrick Y | Director | 2014-11-18 | Purchase | 20,000.0 | $2.35 |
| Yang Patrick Y | Director | 2014-11-17 | Purchase | 20,000.0 | $2.34 |
| CMEA VENTURES LIFE SCIENCES 2000 LP | Director,TenPercentOwner | 2014-11-10 | Sale | 181,067.0 | $2.37 |
| Collier David J | TenPercentOwner | 2014-11-10 | Sale | 181,067.0 | $2.37 |
| Handelsman Karl D. | TenPercentOwner | 2014-11-10 | Sale | 181,067.0 | $2.37 |
| CMEA Ventures LS Management 2000, L.P. | TenPercentOwner | 2014-11-10 | Sale | 181,067.0 | $2.37 |
| CMEA Ventures Life Sciences 2000, Civil Law Partnership | TenPercentOwner | 2014-11-10 | Sale | 181,067.0 | $2.37 |
| CMEA VENTURES LIFE SCIENCES 2000 LP | Director,TenPercentOwner | 2014-11-10 | Sale | 2,740,158.0 | $2.37 |
| Collier David J | TenPercentOwner | 2014-11-10 | Sale | 2,740,158.0 | $2.37 |
| Handelsman Karl D. | TenPercentOwner | 2014-11-10 | Sale | 2,740,158.0 | $2.37 |
| CMEA Ventures LS Management 2000, L.P. | TenPercentOwner | 2014-11-10 | Sale | 2,740,158.0 | $2.37 |
| CMEA Ventures Life Sciences 2000, Civil Law Partnership | TenPercentOwner | 2014-11-10 | Sale | 2,740,158.0 | $2.37 |
| Yang Patrick Y | Director | 2014-08-12 | Purchase | 60,000.0 | $2.22 |
| NICOLS JOHN J | President & CEO | 2013-03-08 | Purchase | 27,000.0 | $2.42 |
| NICOLS JOHN J | President & CEO | 2013-03-07 | Purchase | 27,000.0 | $2.27 |
| NICOLS JOHN J | President & CEO | 2013-03-06 | Purchase | 27,000.0 | $2.16 |
| O'Toole David D | SVP & Chief Financial Officer | 2013-03-04 | Purchase | 10,000.0 | $2.02 |
| O'Toole David D | SVP & Chief Financial Officer | 2012-11-12 | Purchase | 5,000.0 | $2.2 |
| Anton David L. | SVP, BioIndustrials | 2012-09-14 | Sale | 3,800.0 | $2.76 |
| Sheehy Douglas T. | SVP, General Counsel & Sec. | 2012-09-14 | Sale | 3,800.0 | $2.76 |
| O'Toole David D | SVP & Chief Financial Officer | 2012-09-14 | Purchase | 2,500.0 | $2.85 |
| O'Toole David D | SVP & Chief Financial Officer | 2012-09-13 | Purchase | 2,500.0 | $2.7 |
| SHAW ALAN | President and CEO | 2011-12-16 | Sale | 23,846.0 | $5.25 |
| SHAW ALAN | President and CEO | 2011-12-15 | Sale | 30,000.0 | $5.3 |
| SHAW ALAN | President and CEO | 2011-12-14 | Sale | 30,000.0 | $5.26 |
| SHAW ALAN | President and CEO | 2011-12-13 | Sale | 7,820.0 | $5.33 |
| SHAW ALAN | President and CEO | 2011-07-07 | Sale | 13,750.0 | $10.14 |
| SHAW ALAN | President and CEO | 2011-07-06 | Sale | 1,250.0 | $10.01 |
| SHAW ALAN | President and CEO | 2011-06-02 | Sale | 9,600.0 | $10.37 |
| SHAW ALAN | President and CEO | 2011-06-01 | Sale | 5,400.0 | $10.41 |
| Lawson Robert J | SVP and CFO | 2011-05-11 | Purchase | 2,000.0 | $9.5 |
| SHAW ALAN | President and CEO | 2011-05-02 | Sale | 15,000.0 | $10.44 |
| SHAW ALAN | President and CEO | 2011-04-01 | Sale | 15,000.0 | $12.07 |
| SHAW ALAN | President and CEO | 2011-03-01 | Sale | 15,000.0 | $10.65 |
| SHAW ALAN | President and CEO | 2011-02-11 | Sale | 15,000.0 | $10.46 |
| BARUCH THOMAS R | Director | 2010-08-27 | Purchase | 2,500.0 | $7.55 |
| Pasternack Bruce A | Director | 2010-08-24 | Purchase | 3,700.0 | $7.56 |
| Pasternack Bruce A | Director | 2010-08-23 | Purchase | 4,000.0 | $7.88 |
| Pasternack Bruce A | Director | 2010-08-12 | Purchase | 2,300.0 | $7.95 |
| Anton David L. | SVP, Research and Development | 2010-08-10 | Purchase | 2,000.0 | $7.99 |
| Lawson Robert J | SVP and CFO | 2010-08-10 | Purchase | 2,000.0 | $8.0 |
| Sarret Joseph J. | CBO, President Pharmaceuticals | 2010-08-10 | Purchase | 2,000.0 | $7.99 |
| Sheehy Douglas T. | SVP, Gen Counsel and Sec. | 2010-08-10 | Purchase | 1,000.0 | $7.99 |
| SHAW ALAN | President and CEO | 2010-08-10 | Purchase | 2,000.0 | $8.0 |